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Abstract Human organoid systems recapitulate key features of organs offering platforms for 
modelling developmental biology and disease. Tissue- derived organoids have been widely used 
to study the impact of extrinsic niche factors on stem cells. However, they are rarely used to study 
endogenous gene function due to the lack of efficient gene manipulation tools. Previously, we 
established a human foetal lung organoid system (Nikolić et al., 2017). Here, using this organoid 
system as an example, we have systematically developed and optimised a complete genetic toolbox 
for use in tissue- derived organoids. This includes ‘Organoid Easytag’, our efficient workflow for 
targeting all types of gene loci through CRISPR- mediated homologous recombination followed 
by flow cytometry for enriching correctly targeted cells. Our toolbox also incorporates conditional 
gene knockdown or overexpression using tightly inducible CRISPR interference and CRISPR acti-
vation which is the first efficient application of these techniques to tissue- derived organoids. These 
tools will facilitate gene perturbation studies in tissue- derived organoids facilitating human disease 
modelling and providing a functional counterpart to many ongoing descriptive studies, such as the 
Human Cell Atlas Project.
Main
CRISPR and its related techniques (CRISPR interference [CRISPRi] and CRISPR activation [CRISPRa]) 
have transformed the study of gene function in model systems. They have been rapidly adopted in 
cancer and pluripotent stem cell (PSC) lines (Bowden et al., 2020; Gilbert et al., 2013; Tian et al., 
2019), but not in tissue- derived human organoids. We have optimised these genetic tools for use in 
organoids using a tissue- derived human foetal lung organoid system (Nikolić et al., 2017).
First, we aimed to establish a robust workflow for gene targeting in organoids to facilitate reporter 
and direct knockout (KO) generation. A recent application of non- homologous end joining (NHEJ) 
to improve gene targeting in organoids has been successful (Artegiani et al., 2020). However, we 
adopted a homology- directed repair (HDR) strategy as a complementary approach. We reasoned that 
the recombination- based method allows our strategy to deliver precise genetic manipulation with 
flexible targeting sites and minimal additional genetic changes. We chose fluorescence as a selection 
marker, allowing targeted cells to be easily isolated using flow cytometry and chimeric colonies to be 
identified and removed using a fluorescent microscope.
To achieve efficient gene targeting, we first sought to maximise (1) the efficiency of DNA delivery 
into organoid cells and (2) the efficiency of site- specific DNA cleavage by the Cas9- gRNA complex. 
Nucleofection achieved up to 70%  transfection efficiency and showed consistency across different 
organoid lines (Figure 1—figure supplement 1a and b). To optimise site- specific DNA cleavage, we 
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used nucleofection to introduce the Cas9- gRNA complex into cells in different forms (Figure 1—figure 
supplement 1c). Consistent with previous reports, Cas9 ribonucleoproteins (RNPs) outperformed 
plasmid- based Cas9 approaches (Kim et al., 2014; Lin et al., 2014), both in the T7 endonuclease 
assay and an online CRISPR editing analysis tool (Figure 1—figure supplement 1d). Thus, we adopted 
nucleofection and single- stranded synthetic gRNA combined with an RNP (ssRNP) for downstream 
experiments. This strategy has the advantage that the RNP is rapidly degraded and should produce 
minimal off- target effects.
To establish our gene targeting workflow, we first focused on generating a β-actin (ACTB)- fusion 
protein, taking advantage of the abundance of ACTB protein in human foetal lung organoids and a 
previously published targeting strategy (Roberts et  al., 2017). We designed a repair template to 
generate an N terminal monomeric (m)EGFP- ACTB fusion based on the most efficient gRNA tested 
(Figure 1a). We set the following rules for repair template design to facilitate efficient and consistent 
gene targeting: (1) protospacer adjacent motif (PAM) sequence mutated to prevent editing by ssRNP 
(Paquet et al., 2016); (2) 700–1000 nt length of each homologous arm (Yao et al., 2018); (3) minimal 
plasmid size to maximise delivery into organoid cells (<7.0 kb in size recommended empirically) and (4) 
monomeric forms of fluorescent protein to avoid undesirable fusion protein aggregates. As expected, 
72 hr after nucleofection of the ssRNP and repair template, mEGFP+ organoid cells could be enriched 
by flow cytometry (Figure 1b and c). These cells were collected and pooled together, but seeded 
sparsely, and successfully expanded into organoid colonies (Figure  1d). The mEGFP- ACTB fusion 
protein localised to cell–cell junctions as expected (Roberts et al., 2017). These small colonies could 
be further expanded into new organoid lines and 59%  of lines (n = 17/29 lines, from N = 2 parental 
organoid lines, Supplementary file 1) were correctly targeted. Targeted organoids continued to 
express the multipotent lung progenitor marker, SOX9 (Figure 1e). We sought to further increase 
targeting efficiency using drugs previously reported to enhance HDR (Maruyama et al., 2015; Song 
et al., 2016; Yu et al., 2015). However, using flow cytometry as a simple assay, none of the drugs 
tested increased the rate of gene targeting (Figure 1—figure supplement 2).
The AAVS1 locus (Adeno- Associated Virus Integration Site 1, located in the first intron of the 
PPP1R12C gene) has been considered to be a ‘safe harbour locus’ for expressing exogenous genes 
in a controllable manner in human cells without silencing (Smith et al., 2008). As a further proof of 
concept, we successfully targeted AAVS1 to express a membrane tagged TagRFP- T (mTagRFP- T) for 
cell shape visualisation (Figure 1f and g; n = 4/6 correctly targeted lines from N = 1 parental organoid 
line). Therefore, we have combined Cas9 RNP with single- stranded synthetic gRNA, a simple circular 
plasmid repair template and a strategy to enrich correctly targeted cells via flow cytometry for gene 
targeting in human foetal lung organoids. We named this workflow Organoid Easytag.
To expand our Organoid Easytag pipeline to reporter generation, we targeted SOX9. SOX9, a 
transcription factor, is a tip progenitor cell marker for developing lungs (Nikolić et al., 2017), and 
SOX9 reporters are useful for monitoring organoid progenitor state. To overcome its low expression 
level, we used a Histone H2B- EGFP fusion (H2B- EGFP hereafter) to concentrate the EGFP signal in the 
nucleus (Figure 2a). A T2A sequence, a self- cleavage peptide, was also inserted between SOX9 and 
H2B- EGFP to ensure that SOX9 protein was minimally influenced. This strategy allowed us to enrich 
correctly targeted cells by flow cytometry. Targeted colonies could be expanded and maintained 
normal SOX2, SOX9 and NKX2- 1 expression (Figure 2b, Figure 2—figure supplement 1a; n = 9/23 
correctly targeted lines from N = 3 parental organoid lines). Importantly, we noted that although we 
were only able to generate SOX9 reporter lines as heterozygotes (Figure 2—figure supplement 1b 
and c), the gRNA sites in the wildtype alleles were intact (6/6 lines tested, N = 3 parental organoid 
lines) (Figure 2—figure supplement 1d). This offers the opportunity to retarget the second allele 
if desired. To evaluate potential off- target effects, we selected the top nine most probable SOX9 
gRNA off- target sites (Figure 2—figure supplement 1e) and tested if these regions contained any 
undesired CRISPR- induced scars. No indels were detected within ~200 bps flanking these potential 
off- target sites (Figure  2—figure supplement 1e and f), suggesting low off- target effects of our 
workflow (3/3 SOX9- T2A- H2B- EGFP lines tested). Additionally, we validated that the SOX9- targeted 
organoids retained the potential to differentiate (Figure 2—figure supplement 1g), further demon-
strating the normality of the targeted organoid lines.
We sought to apply Organoid Easytag to transcriptionally silent loci to generate differentiation 
reporters. We adopted the strategy of inserting an exogenous promoter flanked by two Rox sites 
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Figure 1. The Organoid Easytag workflow for gene targeting in human organoids. (a) Schematic of the Organoid Easytag workflow. ssRNP and a circular 
plasmid repair template are nucleofected into dissociated cells at day 0. By day 3, cells have proliferated to become tiny colonies and are removed 
from the Matrigel and dissociated for selection by flow cytometry. EGFP+ cells are re- plated sparsely (~1000–1500 cells/well of a 24- well plate) and 
grown until day 15 when organoids reach a sufficient size to be manually picked under a fluorescent microscope. Typically, 10–40 organoid colonies 
formed per ~1000 cells seeded. Organoids are picked into individual wells and passaged until sufficient cells are obtained for both genotyping and 
freezing down the line. Cells with red nuclei represent incorrectly targeted cells. Cells with white nuclei denote correctly targeted cells. (b) Schematic 
of repair template design for N terminal fusion mEGFP- ACTB gene targeting and the final product. Arrow shows the position of gRNA. E1, exon 1; 
E2, exon 2; 5′HA, 5′ homology arm; 3′HA, 3′ homology arm. (c) Representative flow cytometry results showing the percentage of EGFP cells 72 hr 
after nucleofection is performed. (d) Representative image showing mEGFP- ACTB organoid. DIC channel on the left and EGFP channel on the right. 
(e) Immunofluorescence of mEGFP- ACTB organoids. Blue: DAPI (nuclei); green: EGFP (ACTB fusion protein); red: SOX9 (lung progenitor marker). 
Figure 1 continued on next page
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which could be subsequently excised by Dre recombinase (Anastassiadis et  al., 2009; Roberts 
et al., 2019). The exogenous EF1a promoter drives fluorescent reporter expression for flow cytom-
etry selection, allowing us to first positively enrich correctly targeted cells (Venus+), and subsequently 
enrich (Venus-) cells following Dre- mediated EF1a removal (Figure 2—figure supplement 2a). This 
design also helps to minimise the repair template size. We targeted the SFTPC (surfactant protein C, 
Figure 2—figure supplements 2–3) and TP63 genes (Figure 2—figure supplement 4) because they 
are not expressed in human foetal lung organoid cells and are well- established markers for alveolar 
type II and basal cell lineages, respectively (Barkauskas et al., 2013; Rock et al., 2009). To test SFTPC 
reporter function, we overexpressed NKX2- 1 from a lentiviral vector (Figure 2—figure supplement 
2d; Lim et al., 2021). Following NKX2- 1 induction, Venus was co- expressed with proSFTPC protein, 
confirming that the reporter is functional (Figure 2—figure supplement 2e). We noted that the Venus 
signal was cytoplasmic, likely due to inefficient self- cleavage of the T2A sequence (Figure 2—figure 
supplement 2f). TP63 reporter organoid lines were produced using the same strategy (Figure 2—
figure supplement 4). These results indicate that the Organoid Easytag workflow can target silent 
gene loci.
The generation of straightforward gene KOs by induction of indels using the CRISPR- Cas9 system 
can suffer from translation retention and exon skipping (Smits et al., 2019; Tuladhar et al., 2019). 
Moreover, in the absence of a strong, immediate phenotype the KO cells cannot readily be iden-
tified. We sought to solve these problems by generating a gene KO in a controlled manner using 
Organoid Easytag. We focused on SOX2 as its function remains to be elucidated in human foetal lung 
progenitors. We replaced the SOX2 coding sequence (CDS) with T2A- H2B- EGFP to generate SOX2 
KO organoids. Using two gRNAs targeting the N and C terminal of the SOX2 CDS, respectively, we 
sequentially replaced both copies of the SOX2 CDS (Figure 2c, Figure 2—figure supplement 5). The 
EGFP signal was increased after targeting the second copy of the SOX2 CDS, making selection of 
serially targeted alleles by flow cytometry straightforward (Figure 2—figure supplement 5c). SOX2 
KO colonies proliferate and grow normally for at least four serial passages, suggesting that SOX2 is 
not crucial for human foetal lung tip progenitor cell self- renewal (Figure 2d).
Additionally, we tested the Organoid Easytag workflow in the human foetal intestinal organoid 
system (Elmentaite et al., 2020) and successfully derived SOX9 reporter lines (Figure 2e and f; 2/4 
lines tested correctly targeted).
We have demonstrated that our Organoid Easytag pipeline can target various loci, including 
highly abundant genes, transcription factors, the human safe harbour locus and transcriptionally silent 
genes. The Organoid Easytag workflow can also be adapted to generate KOs and applied to different 
organoid systems (efficiency details summarised in Supplementary file 1). Organoid Easytag will be 
a complementary technique to the recently published CRISPR- HOT approach (Artegiani et al., 2020) 
and is particularly suited for experiments where precise gene editing is required (Figure 2—figure 
supplement 5f).
KOs are not suitable for studying the function of genes which are required for stem cell self- 
renewal. Moreover, temporal, and reversible, control of gene expression cannot be easily achieved 
using KOs. Inducible CRISPRi could potentially solve these problems. We first embedded an N- terminal 
KRAB- dCas9 fusion (Mandegar et al., 2016) in a doxycycline (Dox)- inducible TetON system aiming 
to gain temporal control of CRISPRi function. However, the TetON system alone did not provide suffi-
ciently tight control of CRISPRi, possibly due to copy number or integration position of the transgene 
(Figure 3—figure supplement 1). To solve this problem, we fused KRAB- dCas9 with a destabilising 
domain derived from Escherichia coli dihydrofolate reductase (DHFR) (Figure 3a). DHFR is stabilised 
by a small molecule, trimethoprim (TMP) (Figure 3b; Iwamoto et al., 2010). We evaluated the new 
(f) Schematic of the AAVS1 targeting repair template design and the final product. E1, exon 1, E2, exon 2. Arrow indicates the position of the gRNA. 
(g) Immunofluorescence of AAVS1- EF1a- mTagRFP- T organoids. Blue: DAPI (nuclei); red: mTagRFP- T (membrane localised reporter); white: SOX2 (lung 
progenitor marker). Scale bars in all panels denote 50 μm.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Optimisation of DNA delivery and CRISPR cutting.
Figure supplement 2. Small molecules did not significantly improve organoid gene targeting efficiency.
Figure 1 continued
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inducible CRISPRi system by depleting a ubiquitous cell surface marker CD71 (transferrin receptor 
C [TFRC]). Using previously validated gRNAs (Horlbeck et al., 2016), CD71 protein was depleted in 
the majority of the cells after 5 days of Dox and TMP treatment (91.4% ± 2.1%, mean ± SEM, N = 3; 
Figure 3c and d; Figure 3—figure supplement 2a and b). Whereas no knockdown was observed 
in the no Dox/TMP treatment group, or in organoids transduced with non- targeting control gRNA. 
The knockdown effect was achieved after 5  days, could be reversed after 1–2  weeks of Dox and 
TMP removal and then induced again (Figure 3—figure supplement 2a–c), consistent with a recent 
report (Nuñez et al., 2021). We further evaluated the inducible CRISPRi system using SOX2. SOX2 
Figure 2. The Organoid Easytag workflow can be adapted for multiple applications. (a) Schematic of the SOX9 locus repair template design and 
final product. E1, exon 1; E2, exon 2; E3, exon 3; 5′ HA, 5′ homology arm; 3′ HA, 3′ homology arm. Arrow shows the position of the gRNA. (b) 
Immunofluorescence of SOX9- T2A- H2B- EGFP human foetal lung organoids. Green: EGFP (SOX9 reporter); red: SOX9 (lung progenitor marker); white: 
ECAD (E- cadherin, basal- lateral junctions). (c) Schematic showing repair template design and final product for the generation of SOX2 knockout 
organoids using Organoid Easytag. Two gRNA sites were used at the N and C terminal of the SOX2 CDS, respectively. SOX2 CDS was replaced by 
T2A- H2B- EGFP. (d) Representative immunofluorescence showing that SOX2 protein is completely knocked out. Blue: DAPI (nuclei); green: EGFP (SOX2 
transcriptional reporter); red: SOX2 protein (lung progenitor marker); white: ECAD (E- cadherin, basal- lateral junctions). (e) Widefield microscopic images 
showing SOX9 reporter human foetal intestinal organoid. (f) Immunofluorescence of SOX9- T2A- H2B- EGFP human foetal intestinal lung organoids. 
Green: EGFP (SOX9 reporter); red: SOX9; white: CDX2 (intestinal lineage marker). Scale bars denote 50 μm.
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Characterisation of SOX9 targeted colonies.
Figure supplement 2. Organoid Easytag to target silent gene, SFTPC locus.
Figure supplement 3. Characterisation of SFTPC reporter organoids.
Figure supplement 4. Organoid Easytag to target the TP63 locus.
Figure supplement 5. Generation of SOX2 knockout using Organoid Easytag workflow.
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Figure 3. Precise temporal control of CRISPRi in human foetal lung organoids can be achieved via combining the doxycycline (Dox)- inducible system 
with a protein destabilising domain (DD). (a) Schematic of lentiviral vector designs for sequential introduction of inducible CRISPRi and gRNAs into 
human foetal lung organoids. N- terminal KRAB- dCas9 was fused with dihydrofolate reductase (DHFR)- derived DD for stringent control of CRISPRi 
function. EGFP was fused with a C- terminal CAAX domain to achieve membrane labelling of the transduced cells. (b) Schematic showing how the 
temporal control of CRISPRi protein is achieved by combining the Dox- inducible system and DD. The Dox- inducible system is somewhat leaky, but in 
the absence of trimethoprim (TMP), any KRAB- dCas9- DHFR fusion protein produced is degraded. Dox treatment results in high levels of KRAB- dCas9- 
DHFR fusion protein expression. When TMP is not present, the fusion protein is destabilised, whereas when TMP is supplemented, the fusion protein 
Figure 3 continued on next page
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could be efficiently knocked down at both the transcriptional and protein level and no background 
CRISPRi function was observed (Figure 3e and f). The SOX2 knockdown occurred by day 1 and was 
also reversible (Figure 3—figure supplement 2d), indicating that the CRISPRi function is efficient and 
tightly regulated. Consistent with our SOX2 KO, we did not observe effects on organoid morphology 
or growth after SOX2 knockdown (Figure 3g and h). This further confirmed our finding that SOX2 is 
not crucial for organoid self- renewal.
Finally, we have assembled the CRISPRa system to switch on endogenous genes in human foetal 
lung organoids. We tested a previously reported CRISPRa system, dxCas9(3.7)- VPR (Hu et al., 2018), 
for its ability to activate SFTPC transcription (Figure 4). Inducible CRISPRa can induce SFTPC gene 
expression efficiently at both transcriptional and protein level without influencing organoid growth 
(Figure 4b–d).
We have established a complete organoid genetic toolbox for gene targeting, reporter genera-
tion, controllable gene KOs, inducible gene knockdown and gene activation in the human foetal lung 
organoid system (efficiency details provided in Supplementary file 1). We envision that these tools 
can be easily adapted for organoid systems derived from other tissues that are suitable to be nucle-
ofected, or transduced by lentivirus. This will empower tissue- derived organoids to model human 
congenital lung disease and benchmark gene function using the Human Cell Atlas as a reference.
Materials and methods
Human embryonic and foetal lung tissue
Human embryonic and foetal lungs were obtained from terminations of pregnancy from Cambridge 
University Hospitals NHS Foundation Trust under permission from the NHS Research Ethical Committee 
(96/085) and the Joint MRC/Wellcome Trust Human Developmental Biology Resource (London and 
Newcastle, http://www. hdbr. org/) under permission from the NHS Research Ethics Committee (18/
LO/0822 and 18/NE/0290). Samples used had no known genetic abnormalities.
Derivation and maintenance of human foetal lung organoid culture
Human foetal lung organoids were derived and maintained as previously reported (Nikolić et  al., 
2017). Briefly, human foetal lung tissues were dissociated using Dispase (8 U/ml, Thermo Fisher Scien-
tific, 17105041) at room temperature (RT) for 2 min. Mesenchyme was dissected away using needles. 
Tips of the branching epithelium were micro- dissected, transferred into 50 μl of Matrigel (356231, 
is stabilised and can exert its gene expression repression function. (c) Workflow for generating gene knockdown (KD) using CRISPRi system. A parental 
organoid line with inducible CRISPRi was produced via lentiviral transduction followed by sorting for TagRFP- positive cells. Single cells were re- plated 
(~3000–5000 cells/well of a 24- well plate) and expanded for around 17 days. gRNA lentivirus was then introduced by a second lentiviral transduction 
event, followed by sorting for TagRFP/EGFP dual- positive cells after 3 days. Cells were re- plated (~2000–3000 cells/well of a 24- well plate) and expanded 
for another 10 days before treatment with Dox and TMP. 4–6 days after Dox and TMP treatment, gRNA performance was evaluated. (d) Representative 
flow cytometry results for validation of inducible CRISPRi performance using CD71 as a target. After TMP and Dox administration for 5 days, CD71 
protein was successfully downregulated. Grey histogram indicates CD71 expression level for organoids with non- targeting (NT) control gRNA after 
Dox and TMP treatment for 5 days; blue histogram indicates the CD71 expression level for organoids with CD71 gRNA without Dox or TMP treatment, 
showing no KD effect; pink histogram indicates the CD71 expression level for CD71 gRNA with Dox and TMP treatment for 5 days. The figures on the 
graph indicate the percentage of CD71low cells, mean ± SEM. Two independent organoid lines with two different CD71 gRNAs were used. (e) SOX2 
can be effectively knocked down using inducible CRISPRi without leaky effects indicated by qRT- PCR. Organoids with Dox and TMP treatment were 
harvested 5 days after the treatment. Each dot represents an independent experiment. Two independent organoid lines with two different NT control 
gRNAs and three different SOX2 gRNAs were used. SOX2 expression level was normalised to organoids with NT control gRNAs. Detailed breakdown 
of these data is shown in Figure 4—figure supplement 1. Error bars are plotted to show mean ± SEM. A two- sided Student’s t- test with non- equal 
variance was used to compare the means of each group. * indicates p- value < 0.05. n.s. indicates non- significant. (f) Representative western blot results 
showing SOX2 was effectively knocked down using the inducible CRISPRi system (gRNA7 and gRNA8 are independent guides targeted to SOX2; N = 
2 parental organoid lines used). (g–, h) Representative images showing organoid morphology after SOX2 knockdown. Images were taken after 5 days 
of Dox and TMP treatment. SOX2 knockdown (right panel) did not result in obvious phenotypic changes in organoids compared with NT gRNA control 
(left panel). Scale bars denote 100 μm.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. The tetON system alone was not able to tightly control CRISPRi function.
Figure supplement 2. Kinetics and reversibility of the inducible CRISPRi system.
Figure 3 continued
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Corning) and seeded in one well of a 24- well low- attachment plate (M9312- 100EA, Greiner). The plate 
was incubated at 37°C  for 5 min to solidify the Matrigel. 600 μl of self- renewing medium containing 
N2 (1:100, Thermo Fisher Scientific, 17502- 048), B27 (1:50, Thermo Fisher Scientific, 12587- 010), 
N- acetylcysteine (1.25 mM, Merck, A9165), EGF (50 ng/ml, PeproTech, AF- 100- 15), FGF10 (100 ng/
ml, PeproTech, 100- 26), FGF7 (100 ng/ml, PeproTech, 100- 19), Noggin (100 ng/ml, PeproTech, 120- 
10C  ), R- spondin (5%, v/v, Stem Cell Institute, University of Cambridge), CHIR99021 (3  μM, Stem 
Cell Institute, University of Cambridge) and SB 431542 (10 μM, Bio- Techne, 1614) was added. The 
plate was incubated under standard tissue culture conditions (37°C , 5%  CO2). Once formed, organ-
oids were maintained in self- renewing medium and passaged by mechanically breaking using P200 
pipettes every 10–14 days.
Whole-mount immunostaining for human foetal lung organoids
Organoids were fixed with 4%  paraformaldehyde (PFA) directly in the culture plates on ice for 30 min. 
After two PBS washes, 0.5%  (w/v) bovine serum albumin (BSA), 0.2%  Triton- X in PBS (washing solu-
tion) was added and left on ice overnight to dissolve Matrigel. Organoids were then transferred into 
Figure 4. Inducible CRISPRa drove expression of a silent gene, SFTPC, in human foetal lung organoids. (a) Schematic of lentiviral design for introducing 
the CRISPRa system and gRNA into human foetal lung organoids. (b) Representative images to show organoid morphology after SFTPC activation 
after 6 days of doxycycline (Dox) treatment. SFTPC activation (lower panel) did not result in obvious phenotypic changes in organoids compared with 
non- targeting gRNA control (upper panel). (c) SFTPC can be effectively activated by CRISPRa system indicated by qRT- PCR. Each dot represents an 
independent experiment. Two independent organoid lines with two different non- targeting control (NT) gRNAs and three different SFTPC gRNAs 
were used. SFTPC expression level was normalised to organoids with non- targeting control (NT) gRNAs. A detailed breakdown of the results is given 
in Figure 4—figure supplement 1. Error bars are plotted to show mean ± SEM. A two- sided Student’s t- test with non- equal variance was used to 
compare the means of each group. ** indicates p- value < 0.01. (d) Representative immunofluorescence showing proSFTPC protein accumulation 
in organoid cells after CRISPRa activation of SFTPC gene expression. Bright SFTPC protein aggregates accumulated in cells, consistent with the 
hydrophobic nature of SFTPC protein. Green: EGFP; white: proSFTPC protein. Scale bars denote 100 μm (b) and 50 μm (d).
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. SOX2 CRISPRi and SFTPC CRISPRa results break down.
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multiple CellCarrier- 96 Ultra Microplates (PerkinElmer, 6055300) for staining. Subsequently, blocking 
was performed in 5%  donkey serum (Stratech, 017- 000- 121- JIR), 0.5%  (w/v) BSA, 0.2%  Triton- X in PBS 
(blocking solution) at 4°C  overnight. For primary antibody staining, the following antibodies in blocking 
solution were used at 4°C   overnight: SOX2 (1:500, Bio- Techne, AF2018, RRID:AB_355110), SOX9 
(1:500, Merck, AB5535, RRID:AB_2239761), E- cadherin (1:1500, Thermo Fisher Scientific, 13- 1900, 
RRID:AB_2533005), NKX2- 1 (1:500, Abcam, ab76013, RRID:AB_1310784), TagRFP (1:1000, Evrogen, 
AB233, RRID:AB_2571743), GFP/Venus (1:500, Abcam, ab13970, RRID:AB_300798), CDX2 (1:200, 
Abcam, ab157524, RRID:AB_2721036) and proSFTPC (1:500, Merck, AB3786, RRID:AB_91588). After 
washing off the primary antibodies, the following secondary antibodies in washing buffer were used at 
4°C  overnight: donkey anti- chick Alexa 488 (1:2000, Jackson Immune, 703- 545- 155, RRID:AB_2340375), 
donkey anti- rabbit Alexa 594 (1:2000, Thermo Fisher Scientific, A- 21207, RRID:AB_141637), donkey 
anti- goat Alexa 594 (1:2000, Thermo Fisher Scientific, A- 11058, RRID:AB_2534105), donkey anti- 
goat Alexa 647 (1:2000, Thermo Fisher Scientific, A- 21447, RRID:AB_2535864), donkey anti- rat Alexa 
647 (1:2000, Jackson Immune, 712- 605- 153, RRID:AB_2340694) and donkey anti- mouse Alexa 647 
(1:2000, Thermo Fisher Scientific, A31571, RRID:AB_162542). The following day, DAPI (Sigma, D9542) 
staining was performed in washing solution at 4°C   for 30  min. After two washes with PBS, 97%   
(v/v) 2′-2′-thio- diethanol (TDE, Merck, 166782) in PBS was used for mounting. Confocal z stacks were 
acquired using Leica SP8 at an optical resolution of 1024 × 1024 using a ×40 lens. Single- plane images 
are shown. Images were processed using ImageJ (version 2.0.0).
Plasmid nucleofection
For testing transduction efficiency, organoids were dissociated into single cells using pre- warmed 
TrypLE Express (12605028, Thermo Fisher Scientific) at 37°C  for 10 min. The reaction was terminated 
by adding Advanced DMEM/F12 (12634028, Thermo Fisher Scientific) and cells passed through a 
30 μm cell strainer. 2 × 105 organoid single cells were re- suspended with Lonza P3 nucleofection 
buffer and 1 μl of pmaxGFP (Lonza) and transferred to 20 μl nucleofection cuvette (V4XP- 3024, Lonza). 
Nucleofection was performed using Lonza 4D Nucleofector with X unit using the program EA125. 
After nucleofection, self- renewing medium supplemented with 10  μM Y- 27632 (ROCK inhibitor, 
ROCKi, 688000, Merck) was added to dilute the P3 buffer. Cell mixture was then seeded in Matrigel 
in two wells of a 24- well plate and cultured with self- renewing medium with ROCKi (10 μM) for 72 hr 
before FACS analysis.
Lentiviral production
HEK293T cells were kindly provided by Dr. Rick Livesey and tested mycoplasma negative. We grew 
HEK293T cells in 10 cm dishes to a confluence of 80%  before we transfected the lentiviral vector 
(10 μg) with packaging vectors including pMD2.G (3 μg, Addgene plasmid # 12259), psPAX2 (6 μg, 
Addgene plasmid # 12260) and pAdVAntage (3 μg, E1711, Promega) using Lipofectamine 2000 Trans-
fection Reagent (11668019, Thermo Fisher Scientific) according to the manufacturer’s protocol. After 
16 hr, medium was refreshed. Supernatant containing lentivirus was harvested at 24 hr and 48 hr after 
medium refreshing and pooled together. Supernatant was centrifuged at 300 g to remove cell frag-
ments and passed through 0.45 μm filter. Lentivirus containing >10 kb length insert (inducible CRISPRi 
and CRISPRa) was concentrated using AVANTI J- 30I centrifuge (Beckman Coulter) with JS- 24.38 swing 
rotor at 72,000 g for 2 hr at 4°C  and pellets were dissolved in 200 μl PBS. Other lentivirus, including 
gRNA and NKX2- 1- inducible overexpression, were concentrated using Lenti- X Concentrator (631232, 
Takara) and pellets were dissolved in 400 μl PBS.
Lentivirus infection of organoids to test infection efficiency
Organoid single- cell suspension was prepared as for nucleofection. 5  μl lentivirus (CMV- myrAKT- 
IRES- GFP) suspension was applied to 2 × 105 organoid single cells suspended in 500 μl self- renewing 
medium with 10 μM ROCKi (without Matrigel) in one well of 24- well plate and incubated at 37°C   
overnight. The following day, cells were harvested and washed twice with PBS before pelleting and 
seeding in Matrigel in two wells of a 24- well plate. Cells were grown in self- renewing medium with 
ROCKi (10 μM) for 72 hr before flow cytometry. CMV- myrAKT- IRES- GFP was only used for checking 
lentiviral transduction efficiency (Supplementary file 1).
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Lipofectamine transfection of organoids
Organoid single cells were prepared the same way as for nucleofection. For comparing transduc-
tion efficiency, 1 μg of pmaxGFP (Lonza) was mixed with 1 μl of Lipofectamine Stem Transfection 
Reagent (STEM00001, Thermo Fisher Scientific) according to the manufacturer’s protocol. 50 μl reac-
tion mixture was applied to 2 × 105 organoid single cells suspended with 450 μl self- renewing medium 
with ROCKi (without Matrigel) in a single well of a 24- well plate. The plate was then centrifuged at 
32°C  at 600 g for 1 hr, followed by incubation at 37°C  for 2–4 hr. Cells were then harvested, pelleted 
and seeded in Matrigel in two wells of a 24- well plate and grown in self- renewing medium supple-
mented with ROCKi (10 μM) for 72 hr before FACS analysis.
Nucleofection for gene targeting in human foetal lung organoids
Cas9 protein was prepared and used as previously reported (Bruntraeger et al., 1961). If synthetic 
single- strand gRNAs were used, 2  μl spCas9 (4  μg/μl) and 2.88  μl of single- strand synthetic RNA 
(ssRNA, 100 μM, Synthego) were mixed and incubated at RT for a minimum of 10 min in order to 
form ssRNPs. If synthetic crispr/tracer (cr/tr) RNA heterodimers were used, 200  pmol synthetic cr 
RNA (IDT) and 200 pmol synthetic tr RNA (IDT) were mixed with 2.5 μl Nuclease Free Duplex Buffer 
(11- 01- 03- 01, IDT) and denatured at 95°C  for 2 min. 2 μl of cr/tr RNA heterodimer was cooled down 
to RT on the bench, mixed with 2 μl spCas9 (4 μg/μl) and incubated at RT for a minimum of 10 min 
to form cr/tr RNPs. At the same time, organoids were dissociated into single cells, according to the 
protocol previously described for nucleofection. 4 × 105 cells were suspended using Lonza Nucleo-
fection P3 buffer, mixed with 10 μg of appropriate plasmid repair template. The cell suspension was 
further mixed with pre- formed Cas9 RNPs and equally distributed into two 20 μl cuvettes (V4XP- 3032, 
Lonza). Nucleofection was performed using program EA104 for human foetal lung organoids (EA125 
could also be used, but resulted in more cell death). After nucleofection, self- renewing medium with 
ROCKi was added to dilute the P3 buffer. The cell mixture was then taken out and seeded in Matrigel 
in four wells of a 24- well plate and cultured with self- renewing medium with 10 μM ROCKi for 72 hrs 
before flow cytometry.
All gRNAs used for gene targeting were pre- tested for efficient DNA cleavage activity using the T7 
endonuclease assay and ICE analysis (at least 10%  indels, typically 20–30%) before repair template 
design. Sequences used:
ACTB 5′- GCT ATTCTCGCAGCTCACCA TGG,
SOX9 5′- CTTGAGGAGGCCTCCCACGA AGG,
AAVS1 5′- GTCCCCTCCACCCCACAGTG GGG,
SOX2 N terminal 5′- CGGGCCCGCAGCAAACTTCG GGG,
SOX2 C terminal 5′- CGGCCCTCACATGTGTGAGA GGG.
SFTPC 5′- GCGTCCTAGATGTAGTAGAG CGG.
TP63 5′- TGATGCGCTGTTGCTTATTG CGG.
PAM sequences are underlined.
Human foetal intestinal culture and generation of SOX9 reporter 
organoids
Human foetal gut samples at around 9- to 11- week  gestation were obtained with ethical approval 
(REC- 96/085) following maternal consent. Human foetal intestinal organoids were generated from 
the ileum of the tissue and maintained as previously described (Ross et  al., 2021). Briefly, the 
human foetal intestine tissue was placed in a six- well plate and dissociated in a Hank’s Balanced 
Salt Solution (HBSS) medium (14170088, Thermo Fisher Scientific) containing 1.07 Wunsch units/
ml of Liberase DH (5401054001, Merck) on a shaking platform at 750 rpm in a 37°C   incubator 
for 15 min. The sample was then mechanically disrupted by pipetting up and down with a P1000 
pipette, transferred to an Eppendorf tube and centrifuged for 5 min at 400 g. The supernatant 
was removed and the pellet was washed three times with Dulbecco’s Modified Eagle Medium/F12 
(DMEM/F12, 11320033, Thermo Fisher Scientific) by centrifugation. Later, the pellet was re- sus-
pended in Matrigel (Corning, 356231) and seeded in a 48- well plate. The plate was incubated 
at 37°C  for 5 min to solidify the Matrigel and 250 µl of self- renewing medium were added. The 
self- renewing medium for human foetal intestinal organoids contains Wnt3a conditioned medium 
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(50%, v/v, Stem Cell Institute, University of Cambridge), R- spondin- 1 conditioned medium (20%   
v/v, Stem Cell Institute, University of Cambridge), Primocin (500 μg/mL, ant- pm- 2, InvivoGen), B27 
(1:50, 17504044, Thermo Fisher Scientific), nicotinamide (10 mM, N3376, Merck), N- acetylcysteine 
(1.25 mM, A9165, Merck), A3801 (500 nM, 2939, Tocris), SB202190 (10 μM, S7067, Merck), Murine 
EGF (50  ng/mL, PMG8041, Thermo Fisher Scientific) and Murine Noggin (100  ng/mL, 250- 38, 
PeproTech). The medium was replaced every 2–3 days and organoids were passaged by mechan-
ical disruption with a P1000 pipette and re- seeded in Matrigel with fresh self- renewing medium 
every 7–10 days.
For gene targeting, 3 μl spCas9 (4 μg/μl) and 4.32 μl of SOX9 ssRNA (100 μM, Synthego) were 
mixed and incubated at RT for a minimum of 10 min in order to form ssRNPs. At the same time, human 
foetal intestinal organoids were dissociated into single cells, according to the protocol previously 
described for nucleofection. 6 × 105 cells were suspended using Lonza Nucleofection P3 buffer, mixed 
with 6 μg of SOX9 reporter repair template plasmid. The cell suspension was further mixed with pre- 
formed Cas9 RNPs and equally distributed into three 20 μl cuvettes. Nucleofection was performed 
using the program EA125 for human intestinal lung organoids. After nucleofection, intestinal organoid 
maintenance medium with ROCKi was added to dilute the P3 buffer. The cell mixture was then taken 
out and seeded in Matrigel in six wells of a 24- well plate and cultured with maintenance medium with 
10 μM ROCKi for 1 week before flow cytometry.
EGFP+ cells were sorted, harvested and pooled together in 1 × 24- well plate and cultured with 
intestinal organoid maintenance medium with ROCKi before organoid colonies formed. Individual 
organoid colonies were picked based on the expression of EGFP observed using EVOS FL system 
(Thermo Fisher Scientific) microscope and seeded in a 48- well plate to successfully expand them as 
organoid lines. These organoid lines were then harvested for genomic DNA isolation and genotyping.
Small-molecule influence on gene targeting efficiency
mEGFP- ACTB gene targeting was performed as previously described. After nucleofection, DMSO 
(0.6  μl, D2650, Merck), RS- 1 (10  μM, R9782, Merck), L755507 (5  μM, SML1362, Merck) or SCR- 7 (100  
μM, SML1546, Merck) were added to self- renewing medium with ROCKi for 48 hr. Organoid cells were 
analysed by flow cytometry 72 hr after nucleofection.
T7 endonuclease assay
To test for site- specific DNA cleavage using the T7 endonuclease assay, organoid cells were 
harvested 48  hr after nucleofection of ssRNP, tr/cr RNP, plasmid encoding Cas9 and gRNA or 
WT control organoids. Genomic DNA was extracted using QIAamp Fast DNA Tissue Kit (51404, 
Qiagen). PCR was performed using PrimeSTAR GXL DNA Polymerase (R050A, Takara) with 20 ng 
of genomic DNA as template according to the manufacturer’s protocol. Forward primer 5′-TTGC-
CAATGGGGATCGCAG- 3′ and reverse primer 5′- GCTCGATGGGGTACTTCAGG-3′ were used 
for ACTB locus amplification. 10 μl of PCR product was then mixed with 1.5 μl 10X  NEBuffer 2 
(B7002S, NEB) and 1.5 μl of nuclease- free water. The mixture was denatured at 95°C  for 10 min, 
followed by ramp –2°C/s  95°C to 85°C and ramp –0.3°C/s from 85°C to 25°C. 2 μl T7 Endonu-
clease I (1 U/μl, M0302S, NEB) was added and incubated at 37°C  for 1 hr. 2.5%  agarose gel was 
used for electrophoresis.
ICE analysis for indel production
Genomic DNA was extracted from organoid cells which were harvested 48  hr after nucleofection 
of ssRNP, tr/cr RNP, plasmid encoding Cas9 and gRNA or WT control organoids using QIAamp Fast 
DNA Tissue Kit (51404, Qiagen). PCR was performed using PrimeSTAR GXL DNA Polymerase (R050A, 
Takara) with 20 ng of genomic DNA as template according to the manufacturer’s protocol. Forward 
primer 5′-TTGCCAATGGGGATCGCAG- 3′ and reverse primer 5′- GCTCGATGGGGTACTTCAGG- 3′ 
were used for ACTB locus amplification. PCR products were cleaned up using Macherey- Nagel 
NucleoSpin Gel and PCR Clean- up Kit (Macherey- Nagel, 740609.50) and sent for Sanger Sequencing 
(Department of Biochemistry, University of Cambridge) using reverse primer 5′- GCTCGATGGGG-
TACTTCAGG- 3′. Sanger sequencing results were compared using ICE online CRISPR editing analysis 
tool: https://www. synthego. com/ products/ bioinformatics/ crispr- analysis.
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Flow cytometry analysis
Organoid single cells were prepared 72 hr after nucleofection, lentivirus transduction or Lipofectamine 
transfection. Cells were analysed using Sony SH800S Cell Sorter and FlowJo software (version 10.4).
Organoid genotyping
Organoids from a single 48- well plate well were used for genomic DNA extraction with QIAamp Fast 
DNA Tissue Kit (51404, Qiagen) according to the manufacturer’s protocol. PCR was performed using 
PrimeSTAR GXL DNA Polymerase (R050A, Takara) with 20 ng of genomic DNA as template according 
to the manufacturer’s protocol. Primers used are listed in Supplementary file 2. For each gene 
targeting, three randomly picked lines were chosen for further Sanger sequencing. 5′ and 3′ homol-
ogous arms of the gene targeting product were amplified using PrimeSTAR GXL DNA Polymerase 
with the aforementioned primers. PCR products were cleaned up using Macherey- Nagel NucleoSpin 
Gel and PCR Clean- up Kit (Macherey- Nagel, 740609.50) and sequenced using Sanger sequencing 
(Department of Biochemistry, University of Cambridge).
Evaluation of off-target effects
SOX9 gRNA potential off- target sites were identified using the IDT online service: https:// eu. idtdna. 
com/ site/ order/ designtool/ index/ CRISPR_ SEQUENCE. We selected nine potential off- target sites 
with the least mismatches (three mismatches) from all off- target sites with NGG PAM. Primers (Supple-
mentary file 2) were designed to amplify the flanking regions of these sites, purified and sent for 
Sanger sequencing.
Alveolar differentiation of lung organoids
For alveolar differentiation, organoids were transferred to 300 Pa stiffness poly- ethylene- glycol (PEG) 
mixture containing RGD adhesion peptides synthesised in Prof. Matthias Lutolf’s lab as previously 
published (Gjorevski and Lutolf, 2017). Alveolar differentiation medium, containing N2 (1:100, 
Thermo Fisher Scientific, 17502- 048), B27 (1:50, Thermo Fisher Scientific, 12587- 010), N- acetylcys-
teine (1.25 mM, Merck, A9165), FGF10 (100 ng/ml, PeproTech, 100- 26), FGF7 (100 ng/ml, PeproTech, 
100- 19), CHIR99021 (3 μM, Stem Cell Institute, University of Cambridge), dexamethasone (50 nM, 
Merck, D4902), cAMP (0.1  mM, Merck, B5386), IBMX (0.1  mM, Merck, I5879) and DAPT (50  μM, 
Merck, D5942) was used for 6 days.
Western blot
Organoids were harvested, washed twice with Advanced DMEM/F12 and then twice with PBS before 
pelleting at 300 g for 5 min. Organoid cell pellets were re- suspended in 100–200 μl of RIPA buffer 
(Merck, R0278) with protease inhibitor (Thermo Fisher Scientific, 87786) added. Organoid suspension 
was incubated for 30 min on ice, with strong vortex every 5 min. Cell pieces and debris were removed 
by centrifugation at 13,000  rpm. Supernatant was harvested. Protein concentration was measured 
by BCA assay (Thermo Fisher Scientific, 23227). Equal amount of each protein sample was mixed 
with Sample Buffer (Bio- Rad, 1610747) and beta- mercaptoethanol according to the manufacturer’s 
protocol. Mixture was heated at 95°C  for 5 min and cooled down to RT.
Samples were then separated on a 4–12% SDS- PAGE and transferred to nitrocellulose membranes. 
Membrane was blocked by PBS with 5% BSA for 1 hr at RT. Proteins were detected by incubation 
with primary antibodies (SOX2, Bio- Techne, AF2018, 1:1000, RRID:AB_355110; α-Tubulin, Merck, 
T6199, 1:2000, RRID:AB_477583; GFP, Abcam, ab13970, 1:5000, RRID:AB_300798; β-actin, Merck, 
A3854, 1:50,000, RRID:AB_262011) and secondary antibodies (Donkey anti- Goat IRDye 800CW, 
Abcam, ab216775, 1:1000, RRID:AB_2893338; Donkey anti- Mouse IRDye 800CW, ab216774, 1:1000, 
RRID:AB_2893339; IRDye 680LT Donkey anti- Chicken Secondary Antibody, Li- Cor, 925- 68028, 
1:20,000, RRID:AB_2814923). Protein bands were visualised using Li- Cor Odyssey system.
Lentivirus infection of organoids for inducible knockdown and 
activation
Organoids were dissociated into small organoid pieces or single cells using pre- warmed TrypLE 
Express at 37°C  for 5–10 min. Organoid cells were then spun down at 300 g for 5 min. The cell pellet 
of one 24- well plate was re- suspended in 500 μl self- renewing medium with ROCKi. 20 μl of inducible 
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CRISPRi or CRISPRa lentivirus was added and mixed well. The mixture was incubated at 37°C  over-
night. The next morning, organoid cells were pelleted at 300 g for 5 min, washed twice with PBS 
and seeded in 100 μl Matrigel into two wells of a 24- well plate. Organoid cells were cultured with 
self- renewing medium with ROCKi for 3 days before dissociating with TrypLE Express into single cells 
for cell sorting. TagRFP+ cells were sorted using Sony SH800S Cell Sorter and pooled together and 
seeded in Matrigel at ~ 3000–5000 cells/well of a 24- well plate. Organoid cells were then expanded 
for around 17 days using self- renewing medium with ROCKi. At this stage, organoids with inducible 
CRISPRi and CRISPRa system could be frozen as parental lines.
Organoids with inducible CRISPRi and CRISPRa system were broken into small organoid pieces, or 
single cells, similarly and transduced with gRNA lentivirus (5–10 μl virus/500 μl organoid cell re- sus-
pension). The mixture was incubated overnight, and the next morning organoid cells were pelleted, 
washed and seeded with Matrigel as described above. After 3 days of culturing with self- renewing 
medium supplemented with ROCKi, TagRFP and EGFP double- positive cells were sorted and seeded 
in Matrigel at ~2000–3000 cells/well of a 24- well plate and expanded for 10–17 days before turning 
on inducible CRISPRa and CRISPRi. Dox (2 μg/ml, Merck, D9891) and TMP (10 nmol/l, Merck, 92131) 
were supplemented in self- renewing medium accordingly. Medium was refreshed every 48 hr.
For evaluation of inducible CRISPRi using CD71 as target, single cells were prepared as described 
above after 5 days of Dox and TMP treatment. Cells were pelleted at 300 g for 5 min and re- sus-
pended in 100 μl PBS with 0.5%  BSA and 2 mM EDTA. 2.5 μl of PE/Cy7 anti- human CD71 antibody 
(BioLegend, 334111, RRID:AB_2563118) was added and incubated at 4°C  for 30 min. Cells were then 
washed with PBS with 0.5% BSA and 2 mM EDTA twice and re- suspended in 300 μl of PBS with 0.5% 
BSA and 2 mM EDTA for flow cytometry analysis.
RNA extraction, cDNA synthesis and qRT-PCR
Organoids were harvested and washed twice with Advanced DMEM/F12, before 350  μl of RLT 
buffer was added to lyse organoids. RNA extraction was performed according to the manufacturer’s 
protocol using RNeasy Mini Kit (Qiagen, 74104) with RNase- Free DNase Set (Qiagen, 79254). RNA 
concentrations were measured by Nanodrop (Thermo Fisher Scientific). cDNA was synthesised with 
MultiScribe Reverse Transcriptase (Thermo Fisher Scientific, 4311235) according to the manufacturer’s 
protocol. cDNA was diluted 1:25 and 6 μl was used for one qPCR reaction with PowerUp SYBR Green 
Master Mix (Thermo Fisher Scientific, A25776). Relative gene expression was calculated using the 
ΔΔCT method relative to ACTB control.
Plasmid construction
eSpCas9(1.1) was a gift from Feng Zhang (Addgene plasmid # 71814). ACTB gRNA sequence 5′-GCTAT-
TCTCGCAGCTCACC- 3′ was cloned into the vector using BbsI sites. ACTB repair template AICSDP- 15: 
ACTB- mEGFP was a gift from The Allen Institute for Cell Science (Addgene plasmid # 87425). SOX9 
repair template was created by Infusion (638909, Takara) cloning to insert SOX9 5′ and 3′ homologous 
arms in EasyFusion T2A- H2B- GFP plasmid (a gift from Janet Rossant, Addgene plasmid # 112851). 
AAVS1 repair template was created by Infusion cloning to swap the CAG promoter and Puromycin 
resistance cassette in plasmid AICSDP- 42: AAVS1- mTagRFPT- CAAX (a gift from The Allen Institute for 
Cell Science, Addgene plasmid # 107580). SOX2 KO repair template was created by Infusion cloning 
to insert SOX2 5′ and 3′ homologous arms in EasyFusion T2A- H2B- GFP (a gift from Janet Rossant, 
Addgene plasmid # 112851). SFTPC targeting repair template was created by Infusion assembly 
of SFTPC 5′ and 3′ homologous arms together with T2A- Rox- EF1a- Rox- Venus- NLS. TP63 targeting 
repair template was created by Infusion assembly of TP63 5′ and 3′ homologous arms together with 
T2A- Rox- EF1a- Rox- Venus- NLS. CMV- Dre- T2A- TagRFP vector was created by Infusion assembly of Dre 
(a gift from Azim Surani Group, Gurdon Institute, Cambridge) and T2A- TagRFP sequences together. 
NKX2- 1 overexpression vector was created by inserting EF1a- TagRFP- 2A- tet3G and tetON- NKX2- 1 
CDS in two steps cloning using Infusion cloning into a pHAGE backbone. The minimal CMV- GFP(1- 10) 
plasmid was created by Infusion cloning of CMV- GFP(1- 10) from pcDNA3.1- GFP(1- 10) (a gift from 
Bo Huang, Addgene plasmid # 70219) into a pUC57 backbone. For testing lentiviral transduction 
efficiency, CMV- myrAKT- IRES- GFP vector was created by Infusion cloning to insert myrAKT from 
pCCL- Akt1 (a gift from Bi- Sen Ding, Icahn School of Medicine, Mount Sinai) and IRES sequence into 
pFP945 (a gift from Frederick Livesey, University College London). The Dox- inducible CRISPRi vector 
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was created by sub- cloning N- terminal KRAB- dCas9 (a gift from Bruce Conklin, Addgene plasmid # 
73498) into the NKX2- 1 overexpressing vector using XhoI and BamHI sites. Dox- inducible CRISPRi 
with DD control vector was created by In- fusion cloning of a C- terminal DHFR sequence into the Dox- 
inducible CRISPRi vector using BamHI site. The inducible CRISPRa vector was created by sub- cloning 
dxCas9(3.7)- VPR (a gift from David Liu, Addgene plasmid # 108383) into the NKX2- 1 overexpressing 
vector using XhoI and BamHI sites. The gRNA entry vector was cloned by infusion cloning of a EF1a 
promoter into pKLV2- U6gRNA5(BbsI)- PGKpuro2ABFP- W vector (a gift from Kosuke Yusa, Addgene 
plasmid # 67974) using BamHI and EcoRI sites, and then cloned a EGFP- CAAX to swap the EGFP 
sequence using XhoI and NotI sites. All plasmids have been deposited in Addgene: https://www. 
addgene. org/ browse/ article/ 28216212/.
Acknowledgements
We thank Dr. Andrew Bassett (Wellcome Sanger Institute) for the Cas9 expressing vector. We thank 
Prof. Luke Gilbert (UCSF), Prof. Martin Kampmann (UCSF) and Prof. Ruilin Tian (SUSTech) for their 
advice on CRISPRi and CRISPRa. We would like to acknowledge the Gurdon Institute Imaging Facility 
for microscopy support.
DS is supported by a Wellcome Trust PhD studentship (109146/Z/15/Z) and the Department of 
Pathology, University of Cambridge. LDE is supported by the Alzheimer’s Research UK Stem Cell 
Research Centre, funded by the Alborada Trust. VS is supported by a Wellcome Trust PhD studentship 
(102175/B/13/Z). KL is supported by Basic Science Research Program through the National Research 
Foundation of Korea (NRF) funded by the Ministry of Education (2018R1A6A3A03012122). MZ was 
funded by a Medical Research Council (MRC) New Investigator Research Grant (MR/T001917/1). ELR 
is supported by Medical Research Council (MR/P009581/1). Core support from the Wellcome Trust 
(203144/Z/16/Z) and Cancer Research UK (C6946/A24843).
Additional information
Funding
Funder Grant reference number Author
Medical Research Council MR/P009581/1 Emma L Rawlins
Wellcome Trust PhD Studentship 
109146/Z/15/Z
Dawei Sun
Alzheimers Research UK 





Wellcome Trust Core Support for Gurdon 
Institute 203144/Z/16/Z
Emma L Rawlins
Cancer Research UK Core Support for Gurdon 
Institute C6946/A24843
Emma L Rawlins
Medical Research Council New Investigator Research 
Grant MR/T001917/1
Matthias Zilbauer
Wellcome Trust PhD studentship 
102175/B/13/Z
Vanesa Sokleva
The funders had no role in study design, data collection and interpretation, or the 
decision to submit the work for publication.
Author contributions
Dawei Sun, Conceptualization, Formal analysis, Investigation, Writing - original draft, Writing – 
review and editing; Lewis Evans, Kyungtae Lim, Investigation, Writing – review and editing; Fran-
cesca Perrone, Investigation, Resources, Validation; Vanesa Sokleva, Investigation, Validation; Saba 
 Research advance Developmental Biology
Sun et al. eLife 2021;10:e67886. DOI: https:// doi. org/ 10. 7554/ eLife. 67886  15 of 17
Rezakhani, Matthias Lutolf, Methodology, Resources; Matthias Zilbauer, Supervision; Emma L Rawlins, 
Conceptualization, Funding acquisition, Project administration, Supervision, Writing - original draft, 
Writing – review and editing
Author ORCIDs
Dawei Sun    http:// orcid. org/ 0000- 0003- 1551- 4349
Lewis Evans    http:// orcid. org/ 0000- 0001- 7279- 7651
Kyungtae Lim    http:// orcid. org/ 0000- 0001- 6044- 2191
Emma L Rawlins    http:// orcid. org/ 0000- 0001- 7426- 3792
Decision letter and Author response
Decision letter https:// doi. org/ 10. 7554/ 67886. sa1
Author response https:// doi. org/ 10. 7554/ 67886. sa2
Additional files
Supplementary files
•  Transparent reporting form 
•  Supplementary file 1. Summary of genetic manipulation efficiency in different organoid lines.
•  Supplementary file 2. Primers and gRNA sequences used in this study.
•  Supplementary file 3. Raw quantification data. Summary of qRT- PCR results, flow cytometry 
quantification results of DNA delivery efficiency, small- molecule function and CRISPRi kinetics 
analysis and ICE analysis results.
•  Source data 1. Gels and blots.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files.
References
Anastassiadis K, Fu J, Patsch C, Hu S, Weidlich S, Duerschke K, Buchholz F, Edenhofer F, Stewart AF. 2009. 
Dre recombinase, like Cre, is a highly efficient site- specific recombinase in E. coli, mammalian cells and 
mice. Disease Models & Mechanisms 2: 508–515. DOI: https:// doi. org/ 10. 1242/ dmm. 003087, PMID: 
19692579
Artegiani B, Hendriks D, Beumer J, Kok R, Zheng X, Joore I, Chuva de Sousa Lopes S, van Zon J, Tans S, 
Clevers H. 2020. Fast and efficient generation of knock- in human organoids using homology- independent 
CRISPR- Cas9 precision genome editing. Nature Cell Biology 22: 321–331. DOI: https:// doi. org/ 10. 1038/ 
s41556- 020- 0472- 5, PMID: 32123335
Barkauskas CE, Cronce MJ, Rackley CR, Bowie EJ, Keene DR, Stripp BR, Randell SH, Noble PW, Hogan BLM. 
2013. Type 2 alveolar cells are stem cells in adult lung. The Journal of Clinical Investigation 123: 3025–3036. 
DOI: https:// doi. org/ 10. 1172/ JCI68782, PMID: 23921127
Bowden AR, Morales- Juarez DA, Sczaniecka- Clift M, Agudo MM, Lukashchuk N, Thomas JC, Jackson SP. 2020. 
Parallel CRISPR- Cas9 screens clarify impacts of p53 on screen performance. eLife 9: e55325. DOI: https:// doi. 
org/ 10. 7554/ eLife. 55325, PMID: 32441252
Bruntraeger M, Byrne M, Long K, Bassett AR. 1961. Editing the Genome of Human Induced Pluripotent Stem 
Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes. Methods in Molecular Biology 1: 153–183. DOI: 
https:// doi. org/ 10. 1007/ 978- 1- 4939- 9170- 9_ 11
Elmentaite R, Ross ADB, Roberts K, James KR, Ortmann D, Gomes T, Nayak K, Tuck L, Pritchard S, 
Bayraktar OA, Heuschkel R, Vallier L, Teichmann SA, Zilbauer M. 2020. Single- Cell Sequencing of Developing 
Human Gut Reveals Transcriptional Links to Childhood Crohn’s Disease. Developmental Cell 55: 771–783. DOI: 
https:// doi. org/ 10. 1016/ j. devcel. 2020. 11. 010, PMID: 33290721
Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern- Ginossar N, Brandman O, Whitehead EH, 
Doudna JA, Lim WA, Weissman JS, Qi LS. 2013. CRISPR- mediated modular RNA- guided regulation of 
transcription in eukaryotes. Cell 154: 442–451. DOI: https:// doi. org/ 10. 1016/ j. cell. 2013. 06. 044, PMID: 
23849981
Gjorevski N, Sachs N, Manfrin A, Giger S, Bragina ME, Ordóñez- Morán P, Clevers H, Lutolf MP. 2016. Designer 
matrices for intestinal stem cell and organoid culture. Nature 539: 560–564. DOI: https:// doi. org/ 10. 1038/ 
nature20168, PMID: 27851739
Gjorevski N, Lutolf MP. 2017. Synthesis and characterization of well- defined hydrogel matrices and their 
application to intestinal stem cell and organoid culture. Nature Protocols 12: 2263–2274. DOI: https:// doi. org/ 
10. 1038/ nprot. 2017. 095, PMID: 28981121
 Research advance Developmental Biology
Sun et al. eLife 2021;10:e67886. DOI: https:// doi. org/ 10. 7554/ eLife. 67886  16 of 17
Horlbeck MA, Gilbert LA, Villalta JE, Adamson B, Pak RA, Chen Y, Fields AP, Park CY, Corn JE, Kampmann M, 
Weissman JS. 2016. Compact and highly active next- generation libraries for CRISPR- mediated gene repression 
and activation. eLife 5: e19760. DOI: https:// doi. org/ 10. 7554/ eLife. 19760, PMID: 27661255
Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, Zeina CM, Gao X, Rees HA, Lin Z, Liu DR. 2018. Evolved 
Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556: 57–63. DOI: https:// doi. org/ 
10. 1038/ nature26155, PMID: 29512652
Iwamoto M, Björklund T, Lundberg C, Kirik D, Wandless TJ. 2010. A General Chemical Method to Regulate 
Protein Stability in the Mammalian Central Nervous System. Chemistry & Biology 17: 981–988. DOI: https:// 
doi. org/ 10. 1016/ j. chembiol. 2010. 07. 009, PMID: 20851347
Kim S, Kim D, Cho SW, Kim J, Kim JS. 2014. Highly efficient RNA- guided genome editing in human cells via 
delivery of purified Cas9 ribonucleoproteins. Genome Research 24: 1012–1019. DOI: https:// doi. org/ 10. 1101/ 
gr. 171322. 113, PMID: 24696461
Lim K, Tang W, Sun D, He P, Teichmann SA, Marioni JC, Meyer KB, Rawlins EL. 2021. Acquisition of Alveolar Fate 
and Differentiation Competence by Human Fetal Lung Epithelial Progenitor Cells. [bioRxiv]. DOI: https:// doi. 
org/ 10. 1101/ 2021. 06. 30. 450501
Lin S, Staahl BT, Alla RK, Doudna JA. 2014. Enhanced homology- directed human genome engineering by 
controlled timing of CRISPR/Cas9 delivery. eLife 3: e04766. DOI: https:// doi. org/ 10. 7554/ eLife. 04766, PMID: 
25497837
Mandegar MA, Huebsch N, Frolov EB, Shin E, Truong A, Olvera MP, Chan AH, Miyaoka Y, Holmes K, Spencer CI, 
Judge LM, Gordon DE, Eskildsen TV, Villalta JE, Horlbeck MA, Gilbert LA, Krogan NJ, Sheikh SP, Weissman JS, 
Qi LS, et al. 2016. CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human 
iPSCs. Cell Stem Cell 18: 541–553. DOI: https:// doi. org/ 10. 1016/ j. stem. 2016. 01. 022, PMID: 26971820
Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL. 2015. creasing the efficiency of 
precise genome editing with CRISPR- Cas9 by inhibition of nonhomologous end joining. Nature Biotechnology 
33: 538–542. DOI: https:// doi. org/ 10. 1038/ nbt. 3190, PMID: 25798939
Nikolić MZ, Caritg O, Jeng Q, Johnson JA, Sun D, Howell KJ, Brady JL, Laresgoiti U, Allen G, Butler R, 
Zilbauer M, Giangreco A, Rawlins EL. 2017. Human embryonic lung epithelial tips are multipotent progenitors 
that can be expanded in vitro as long- term self- renewing organoids. eLife 6: e26575. DOI: https:// doi. org/ 10. 
7554/ eLife. 26575, PMID: 28665271
Nuñez JK, Chen J, Pommier GC, Cogan JZ, Replogle JM, Adriaens C, Ramadoss GN, Shi Q, Hung KL, 
Samelson AJ, Pogson AN, Kim JYS, Chung A, Leonetti MD, Chang HY, Kampmann M, Bernstein BE, 
Hovestadt V, Gilbert LA, Weissman JS. 2021. Genome- wide programmable transcriptional memory by 
CRISPR- based epigenome editing. Cell 184: 2503–2519. DOI: https:// doi. org/ 10. 1016/ j. cell. 2021. 03. 025, 
PMID: 33838111
Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier- Lavigne M. 2016. 
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533: 
125–129. DOI: https:// doi. org/ 10. 1038/ nature17664, PMID: 27120160
Roberts B, Haupt A, Tucker A, Grancharova T, Arakaki J, Fuqua MA, Nelson A, Hookway C, Ludmann SA, 
Mueller IA, Yang R, Horwitz R, Rafelski SM, Gunawardane RN. 2017. Systematic gene tagging using CRISPR/
Cas9 in human stem cells to illuminate cell organization. Molecular Biology of the Cell 28: 2854–2874. DOI: 
https:// doi. org/ 10. 1091/ mbc. e17- 03- 0209, PMID: 28814507
Roberts B, Hendershott MC, Arakaki J, Gerbin KA, Malik H, Nelson A, Gehring J, Hookway C, Ludmann SA, 
Yang R, Haupt A, Grancharova T, Valencia V, Fuqua MA, Tucker A, Rafelski SM, Gunawardane RN. 2019. 
Fluorescent Gene Tagging of Transcriptionally Silent Genes in hiPSCs. Stem Cell Reports 12: 1145–1158. DOI: 
https:// doi. org/ 10. 1016/ j. stemcr. 2019. 03. 001, PMID: 30956114
Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, Randell SH, Hogan BLM. 2009. Basal cells as stem cells of 
the mouse trachea and human airway epithelium. PNAS 106: 12771–12775. DOI: https:// doi. org/ 10. 1073/ pnas. 
0906850106, PMID: 19625615
Ross ADB, Perrone F, Elmentaite R, Teichmann SA, Zilbauer M. 2021. Obtaining purified human intestinal 
epithelia for single- cell analysis and organoid culture. STAR Protocols 2: 100597. DOI: https:// doi. org/ 10. 1016/ 
j. xpro. 2021. 100597, PMID: 34169291
Smith JR, Maguire S, Davis LA, Alexander M, Yang F, Chandran S, ffrench- Constant C, Pedersen RA. 2008. 
Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1- targeted 
integration. Stem Cells 26: 496–504. DOI: https:// doi. org/ 10. 1634/ stemcells. 2007- 0039, PMID: 18024421
Smits AH, Ziebell F, Joberty G, Zinn N, Mueller WF, Clauder- Münster S, Eberhard D, Fälth Savitski M, Grandi P, 
Jakob P, Michon AM, Sun H, Tessmer K, Bürckstümmer T, Bantscheff M, Steinmetz LM, Drewes G, Huber W. 
2019. Biological plasticity rescues target activity in CRISPR knock outs. Nature Methods 16: 1087–1093. DOI: 
https:// doi. org/ 10. 1038/ s41592- 019- 0614- 5, PMID: 31659326
Song J, Yang D, Xu J, Zhu T, Chen YE, Zhang J. 2016. RS- 1 enhances CRISPR/Cas9- and TALEN- mediated 
knock- in efficiency. Nature Communications 7: 1–7. DOI: https:// doi. org/ 10. 1038/ ncomms10548, PMID: 
26817820
Tian R, Gachechiladze MA, Ludwig CH, Laurie MT, Hong JY, Nathaniel D, Prabhu AV, Fernandopulle MS, Patel R, 
Abshari M, Ward ME, Kampmann M. 2019. CRISPR Interference- Based Platform for Multimodal Genetic 
Screens in Human iPSC- Derived Neurons. Neuron 104: 239–255. DOI: https:// doi. org/ 10. 1016/ j. neuron. 2019. 
07. 014, PMID: 31422865
Tuladhar R, Yeu Y, Tyler Piazza J, Tan Z, Rene Clemenceau J, Wu X, Barrett Q, Herbert J, Mathews DH, Kim J, 
Hyun Hwang T, Lum L. 2019. CRISPR- Cas9- based mutagenesis frequently provokes on- target mRNA 
 Research advance Developmental Biology
Sun et al. eLife 2021;10:e67886. DOI: https:// doi. org/ 10. 7554/ eLife. 67886  17 of 17
misregulation. Nature Communications 10: 1–10. DOI: https:// doi. org/ 10. 1038/ s41467- 019- 12028- 5, PMID: 
31492834
Yao X, Zhang M, Wang X, Ying W, Hu X, Dai P, Meng F, Shi L, Sun Y, Yao N, Zhong W, Li Y, Wu K, Li W, Chen ZJ, 
Yang H. 2018. Tild- CRISPR Allows for Efficient and Precise Gene Knockin in Mouse and Human Cells. 
Developmental Cell 45: 526–536. DOI: https:// doi. org/ 10. 1016/ j. devcel. 2018. 04. 021, PMID: 29787711
Yu C, Liu Y, Ma T, Liu K, Xu S, Zhang Y, Liu H, La Russa M, Xie M, Ding S, Qi LS. 2015. Small Molecules Enhance 
CRISPR Genome Editing in Pluripotent Stem Cells. Cell Stem Cell 16: 142–147. DOI: https:// doi. org/ 10. 1016/ j. 
stem. 2015. 01. 003, PMID: 25658371
